Nick Wykeman
Chief Executive Officer at Bencard Allergie GmbH
Net worth: 23 664 $ as of 2024-04-29
Profile
Nicolas Alexander Ulrich Wykeman is currently a Director at Allergy Therapeutics (UK) Ltd., a Director at Allergy Therapeutics (Holdings) Ltd., a Managing Director at Bencard Allergie GmbH, and a Member of the Institute of Chartered Accountants in England & Wales.
Previously, he served as the Chief Financial Officer & Executive Director at Allergy Therapeutics Plc from 2016 to 2022.
Prior to that, he was the Group Financial Controller at SkyePharma Plc, Deloitte & Touche LLP UK, and Quest International Ltd.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
ALLERGY THERAPEUTICS PLC
0.01% | 2023-06-29 | 651,724 ( 0.01% ) | 23 664 $ | 2024-04-29 |
Nick Wykeman active positions
Companies | Position | Start |
---|---|---|
Institute of Chartered Accountants in England & Wales
Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Corporate Officer/Principal | - |
Allergy Therapeutics (UK) Ltd.
Allergy Therapeutics (UK) Ltd. Medical SpecialtiesHealth Technology Part of Azure Ventures Ltd., Allergy Therapeutics (UK) Ltd. is a British company that specializes in treating various types of allergies. The company is based in Worthing, UK. The information provided in the dictionary is limited to the company's home page, history, mission, vision, and login page. | Director/Board Member | - |
Bencard Allergie GmbH
Bencard Allergie GmbH Medical SpecialtiesHealth Technology Part of Allergy Therapeutics Plc, Bencard Allergie GmbH is a German company that specializes in researching and developing drugs for the diagnosis and causal therapy of allergies. The company is based in Munich, Germany. The company's website provides concise knowledge on various allergy detection and treatment methods. Bencard Allergie was founded in 1934 and is currently led by CEOs Manuel Llobet, Bodo Steinert, and Nicolas Alexander Ulrich Wykeman. | Chief Executive Officer | - |
Allergy Therapeutics (Holdings) Ltd.
Allergy Therapeutics (Holdings) Ltd. Financial ConglomeratesFinance Part of SkyGem International Holdings Ltd., Allergy Therapeutics (Holdings) Ltd. is an investment holding British company. The company is based in Worthing, UK. Founded in 1998, Allergy Therapeutics (Holdings functions as an investment holding company. | Director/Board Member | 2016-06-08 |
Former positions of Nick Wykeman
Companies | Position | End |
---|---|---|
ALLERGY THERAPEUTICS PLC | Director of Finance/CFO | 2022-11-29 |
SKYEPHARMA PLC | Comptroller/Controller/Auditor | 2015-07-31 |
Deloitte & Touche LLP UK
Deloitte & Touche LLP UK Miscellaneous Commercial ServicesCommercial Services Part of Deloitte LLP (New York), Deloitte & Touche LLP UK provides financial advisory and accounting services. The company is based in Edinburgh, UK. | Comptroller/Controller/Auditor | - |
Quest International Ltd. | Comptroller/Controller/Auditor | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ALLERGY THERAPEUTICS PLC | Health Technology |
Private companies | 7 |
---|---|
SkyePharma Plc
SkyePharma Plc Pharmaceuticals: OtherHealth Technology SkyePharma Plc engaged in the provision of pharmaceutical business. It involved in development and supply of pharmaceutical products. The company was founded by Ian Roderick Gowrie-Smith on August 18, 1910 and was headquartered in London, the United Kingdom. | Health Technology |
Institute of Chartered Accountants in England & Wales
Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Commercial Services |
Deloitte & Touche LLP UK
Deloitte & Touche LLP UK Miscellaneous Commercial ServicesCommercial Services Part of Deloitte LLP (New York), Deloitte & Touche LLP UK provides financial advisory and accounting services. The company is based in Edinburgh, UK. | Commercial Services |
Allergy Therapeutics (UK) Ltd.
Allergy Therapeutics (UK) Ltd. Medical SpecialtiesHealth Technology Part of Azure Ventures Ltd., Allergy Therapeutics (UK) Ltd. is a British company that specializes in treating various types of allergies. The company is based in Worthing, UK. The information provided in the dictionary is limited to the company's home page, history, mission, vision, and login page. | Health Technology |
Quest International Ltd. | |
Allergy Therapeutics (Holdings) Ltd.
Allergy Therapeutics (Holdings) Ltd. Financial ConglomeratesFinance Part of SkyGem International Holdings Ltd., Allergy Therapeutics (Holdings) Ltd. is an investment holding British company. The company is based in Worthing, UK. Founded in 1998, Allergy Therapeutics (Holdings functions as an investment holding company. | Finance |
Bencard Allergie GmbH
Bencard Allergie GmbH Medical SpecialtiesHealth Technology Part of Allergy Therapeutics Plc, Bencard Allergie GmbH is a German company that specializes in researching and developing drugs for the diagnosis and causal therapy of allergies. The company is based in Munich, Germany. The company's website provides concise knowledge on various allergy detection and treatment methods. Bencard Allergie was founded in 1934 and is currently led by CEOs Manuel Llobet, Bodo Steinert, and Nicolas Alexander Ulrich Wykeman. | Health Technology |
- Stock Market
- Insiders
- Nick Wykeman